Top 10 worst performing Cathie Wood ARKK holdings of 2024

Cathie Wood’s flagship ARK Innovation ETF (NYSEARCA:ARKK) continues its downward struggle this week despite a move higher on Friday afternoon. The innovation focused ETF currently trades lower on the week by 5.3% and lower on the year by 8.7%.

ARKK’s move lower is not completely attributed to the struggles of tech but rather its more isolated to the exchange traded fund itself. As the tech focused Nasdaq Composite (COMP:IND) is higher on the year by 9.5% and the Nasdaq 100 focused ETF Invesco QQQ Trust (QQQ) is higher on the year by 8.8%. Furthermore, Info Tech represents the third best performing sector in 2024.

Looking under the hood of ARKK and investors will see that the fund is constructed of 37 names of which, only 10 trade in positive territory in 2024. From a portfolio allocation standpoint, the 10 names that are positive together represent 32.19% of the ETF with Coinbase Global (COIN) being the biggest contributor with a 9.86% allocation in ARKK.

At the other end of the spectrum, 27 of ARKK’s holdings have been a drag on the fund with 21 of the 27 names down at least 10% or more. Listed below are the 10 worst performing names inside ARKK during 2024.

Top 10 Worst Performing Holdings of ARKK

No. 10: Teladoc Health (TDOC) -32.5% YTD.

No. 9: Tesla (TSLA) -33.4% YTD.

No. 8: Roku (ROKU) -34.5% YTD.

No. 7: Prime Medicine (PRME) -34.6% YTD.

No. 6: 10x Genomics (TXG) -35.2% YTD.

No. 5: Ginkgo Bioworks (DNA) -35.8% YTD.

No. 4: Unity Software (U) -37.7% YTD.

No. 3: Verve Therapeutics (VERV) -38.1% YTD.

No. 2: Pacific Biosciences of California (PACB) -65.5% YTD.

No. 1: 2U, Inc. (TWOU) -70.9% YTD.

In total, the top 10 worst performing names inside of ARKK together represent 27.75% of the exchange traded funds portfolio.